Cargando…
MiR-1260b inhibitor enhances the chemosensitivity of colorectal cancer cells to fluorouracil by targeting PDCD4/IGF1
Colorectal cancer (CRC) is the most common malignant tumor type and has become resistant to 5-fluorouracil (5-FU) in recent decades, which is one of the most popular therapies. Recently, microRNA (miRNA or miR) has been investigated as a potential therapeutic strategy for CRC. However, there has bee...
Autores principales: | Zhao, Jun, Cao, Jingjie, Zhou, Lurong, Du, Yunyi, Zhang, Xiaoling, Yang, Bo, Gao, Yangjun, Wang, Yu, Ma, Ning, Yang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144919/ https://www.ncbi.nlm.nih.gov/pubmed/30250581 http://dx.doi.org/10.3892/ol.2018.9307 |
Ejemplares similares
-
miR-1260b is a Potential Prognostic Biomarker in Colorectal Cancer
por: Liu, Deng-Rui, et al.
Publicado: (2016) -
miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer
por: Karaayvaz, M, et al.
Publicado: (2013) -
miR-150 Modulates Cisplatin Chemosensitivity and Invasiveness of Muscle-Invasive Bladder Cancer Cells via Targeting PDCD4 In Vitro
por: Lei, Ye, et al.
Publicado: (2014) -
Function and regulation of miR-186-5p, miR-125b-5p and miR-1260a in chordoma
por: Huo, Xulei, et al.
Publicado: (2023) -
High expression level of miR-1260 family in the peripheral blood of patients with ovarian carcinoma
por: Ghafour, Arash Adamnejad, et al.
Publicado: (2021)